Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
GOOG	9,377,195	$343.58	$3,221,816,659
HLT	9,332,853	$329.93	$3,079,188,191
	15,095,528	$195.32	$2,948,458,529
QSR	23,348,135	$81.36	$1,899,604,264
LOW	7,468,850	$215.64	$1,610,582,814
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$346.96	$758,107,600
CMG	953,608	$37.63	$35,884,270
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Mar 28, 2016 11:49AM Valeant CEO subpoenaed to testify before U.S. Senate panel
Mar 25, 2016 02:24PM Senate's request for info from Ackman related to Valeant: source
Mar 25, 2016 10:17AM Fitch: Pershing Square Holdings' 'BBB+' Ratings Not Yet Impacted by Valeant Decline
Mar 24, 2016 05:50PM Ackman Doesn't See 'Slap on the Wrist' for Herbalife (HLF)
Mar 24, 2016 05:42PM Ackman Sees Confidence Restored in Valeant Pharma (VRX) After 10-K Filed, New Leadership Identified
Mar 24, 2016 04:31PM Ackman's hedge fund cooperating with U.S. on drug pricing probe: letter
Mar 23, 2016 10:13AM Ackman Skipping Sohn Investment Conference to Focus on Valeant (VRX)
Mar 23, 2016 07:02AM The Howard Hughes Corporation® Issues Letter to Shareholders
Mar 22, 2016 10:39AM Valeant Pharma (VRX) Gains as Ackman Gets Hands On
Mar 21, 2016 11:34AM Valeant (VRX) is Not Investable - Piper Jaffray
Mar 21, 2016 11:07AM Valean (VRX) Changes Seen as Steps in the Right Direction - BMO Capital
Mar 21, 2016 10:00AM Mizuho Sees More Volatility for Valeant (VRX) Amid Changes
Mar 21, 2016 09:13AM Drugmaker Valeant CEO leaving as investor Ackman joins board
Mar 21, 2016 08:59AM Valeant Pharma (VRX) to Replace CEO Pearson; Adds Bill Ackman to Board
Mar 21, 2016 08:58AM Valeant Announces CEO Succession Plan And Changes To Board Of Directors; Provides Accounting And Financial Reporting Update
Mar 21, 2016 07:25AM Wall St. ends flat as recent rally spurs caution
Mar 18, 2016 05:50PM Activist hedge funds wounded by market turmoil
Mar 17, 2016 04:32PM S&P says it may cut Ackman hedge fund's rating
Mar 17, 2016 01:39PM Herbalife (HLF) Creeps Higher on Anti-Ackman Trade
Mar 17, 2016 12:05PM Bill Ackman tells CNBC Valeant (VRX) "is a problem but we know what to do."
Mar 17, 2016 12:03PM Bill Ackman tells CNBC next redemption Mid-May
Mar 17, 2016 12:02PM Bill Ackman tells CNBC 'we don't use margin leverage - never have and never will' (VRX)
Mar 17, 2016 09:31AM Pre-Open Stock Movers 03/17: (VTAE) (RSTI) (AQXP) Higher; (SXE) (ORPN) (SALT) Lower (more...)
Mar 16, 2016 06:19PM After-Hours Stock Movers 03/16: (VTAE) (RSTI) (FDX) Higher; (GES) (SALT) (JBL) Lower (more...)
Mar 16, 2016 06:02PM Ackman sells part of Mondelez stake, has no plans for other sales
Mar 16, 2016 05:28PM Ackman's Pershing Square Trims Stake in Mondelez Int'l (MDLZ) to 5.6%
Mar 16, 2016 05:10PM Valeant Pharma (VRX) Gains on Ackman Chatter
Mar 16, 2016 04:56PM Mondelez Int'l (MDLZ) Lower on Word Ackman Selling Some Stock
Mar 15, 2016 05:02PM Valeant's stock rout serves up $5.3 billion in hedge fund losses
Mar 15, 2016 03:58PM Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
Mar 15, 2016 03:24PM Ackman's Pershing Square Said to Support Valeant Pharma (VRX) CEO Pearson; Wants More Oversight - Bloomberg
Mar 15, 2016 11:28AM Ackman's Pershing Square Said Down $666M+ This Week on Valeant Pharma (VRX) Stake
Mar 15, 2016 08:37AM Herbalife (HLF) Shelled Out ~$700,000 Last Year to Protect CEO Johnson
Mar 15, 2016 06:20AM Drugmaker Valeant faces debt default risk; shares plunge 50 percent
Mar 14, 2016 03:37PM Pershing Square Holdings, Ltd. Announces First Quarter 2016 Investor Call and Annual London Investor Meeting
Mar 11, 2016 06:19PM Valeant under pressure to beef up management as new board meets
Mar 10, 2016 02:30PM Hedge funds score tiny gains in February - HFR data
Mar 9, 2016 08:52AM Valeant gives Pershing Square 1 board seat, adds 2 other directors
Mar 9, 2016 08:11AM Valeant gives Pershing Square a seat on its board
Mar 8, 2016 05:32PM After-Hours Stock Movers 03/08: (BUFF) (CISG) (AVAV) Higher; (STEM) (PLNT) (ZAGG) Lower (more...)
Mar 8, 2016 05:01PM Valeant to appoint three new directors as soon as Wednesday: sources
Mar 8, 2016 04:43PM Valeant Pharma (VRX) Said in Talks to Add New Director; May Come from Ackman's Pershing Square
Mar 7, 2016 05:06PM Hedge funds score tiny gains in February: HFR data
Mar 4, 2016 07:00AM WPP 2015 Preliminary Results
Mar 2, 2016 09:32AM Ackman's Pershing Square Down 19.9% YTD in 2016
Mar 1, 2016 06:38PM Ackman's Pershing Square Holdings fund down 19.9 percent in 2016
Feb 29, 2016 02:55PM Boys & Girls Harbor Ninth Annual Harbor Investment Conference to Feature Ideas and Insights of Industry-Leading Investment Managers
Feb 25, 2016 06:15PM Herbalife says it is in talks with FTC; outcome uncertain
Feb 24, 2016 04:50PM Ackman's fund off 17.3 percent for year, erases banner gains from 2014
Feb 12, 2016 07:48PM Loeb says Third Point raised short bets to avoid losses

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed